139 related articles for article (PubMed ID: 2579948)
1. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
Harpel PC; Lewin MF; Kaplan AP
J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
[TBL] [Abstract][Full Text] [Related]
2. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
Lewin MF; Kaplan AP; Harpel PC
J Biol Chem; 1983 May; 258(10):6415-21. PubMed ID: 6343376
[TBL] [Abstract][Full Text] [Related]
3. Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and without amyloidosis. Increased kaolin-stimulated activity in patients with amyloidosis.
Teppo AM; Pakkanen R; Maury CP
Acta Med Scand; 1985; 217(4):397-402. PubMed ID: 2409750
[TBL] [Abstract][Full Text] [Related]
4. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
Harpel PC
J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
[TBL] [Abstract][Full Text] [Related]
5. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
6. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
7. Plasma kallikrein activation and inhibition during typhoid fever.
Colman RW; Edelman R; Scott CF; Gilman RH
J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
9. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
Veloso D; Tseng SY; Craig AR; Colman RW
Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
[No Abstract] [Full Text] [Related]
10. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
Kaplan AP; Gruber B; Harpel PC
Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
[TBL] [Abstract][Full Text] [Related]
12. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
13. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
14. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
[TBL] [Abstract][Full Text] [Related]
15. Western blot analyses of prekallikrein and its activation products in human plasma.
Veloso D; Colman RW
Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
[TBL] [Abstract][Full Text] [Related]
16. Studies on a kallikrein-kinin system in plasma of patients with acute pancreatitis: the preparation and characterization of a kallikrein-like enzyme in patient's plasma.
Takasugi S; Toki N
Clin Biochem; 1980 Aug; 13(4):156-9. PubMed ID: 6160922
[TBL] [Abstract][Full Text] [Related]
17. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
Roeise O; Bouma BN; Stadaas JO; Aasen AO
Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
[TBL] [Abstract][Full Text] [Related]
18. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
Kluft C
J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
[TBL] [Abstract][Full Text] [Related]
19. Human plasma kallikrein: purification, enzyme characterization and quantitative determination in plasma.
Heber H; Geiger R; Heimburger N
Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):659-69. PubMed ID: 97200
[TBL] [Abstract][Full Text] [Related]
20. Pathways of kinin formation and role in allergic diseases.
Kaplan AP; Silverberg M; Ghebrehiwet B; Atkins P; Zweiman B
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S41-51. PubMed ID: 2910589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
